I wouldn't be so sure on the omission of a profit upgrade. FY16 had target revenue of 105m with profit upgrade issued to 120m and revenue came in at 127m. This was 5% beyond guidance and I'm happy for a company to not be over exuberant with issuing guidance figures. When you're forecasting 15% growth at the top end and to exceed that by 5% = +33%.
Put into perspective, RXP to meet upper end of FY17 guidance is $146m of which $70.6m was achieved in the first half and the company generally reports much higher 2nd half profits. What caught my interest is that the company declared similar growth for FY18 with revenue +10-15% and EBITDA margin 13-14%.